The cost of the handoff

Three hours in the OR. Three decades of recovery ahead.

That's the reality for most transplant recipients. The surgery gets the spotlight—the technical achievement, the life saved, the grateful family in the waiting room. But the real work starts when patients go home: complex medication regimens, fluctuating symptoms, mental health challenges, and a healthcare system that often treats post-transplant care as an afterthought.

The consequences show up in the data. Nonadherent kidney transplant patients face 7x higher odds of graft failure.¹ Medicare claims show poor compliance drives an 80% increased risk of graft loss and $12,840 higher costs over three years.² Between 15% and 58% of recipients show irregular medication-taking behaviors, with adherence declining 4.8% annually after transplant.³

The surgery succeeds. The system fails. Patients pay the price.

But it doesn't have to work this way.

Engagement is modifiable

Patient activation—the knowledge, skills, and confidence to manage one's own health—directly predicts outcomes. And crucially, activation isn't fixed.

Patients who start with low engagement often show the largest improvements when they receive targeted support: education, coaching, digital tools.⁴ Every critical post-transplant behavior depends on engagement. Taking immunosuppressants consistently. Monitoring symptoms accurately. Communicating problems quickly.

Patients who feel informed and supported do these things. Patients who feel abandoned after discharge often don't.

The question becomes: what support actually works?

The transplant-specific evidence

A 2025 systematic review and meta-analysis—the first focused specifically on kidney transplant recipients—examined 12 randomized controlled trials with 1,234 patients.³

The findings: eHealth interventions using electronic monitoring improved medication adherence significantly (RR 1.46, p=.006). Interventions combining multiple components—reminders, self-monitoring, clinician feedback—showed the most promise.

But the review also identified critical gaps. Simple reminder apps without human connection showed high attrition. Ceiling effects limited impact in already-adherent populations. And conventional interventions remain "constrained by limited spatiotemporal accessibility, workforce burdens, and patient passivity."

Translation: technology alone isn't enough. Technology combined with human support changes outcomes.

Two-way messaging works—in transplant

A 2025 RCT tested SMS reminders specifically in kidney transplant recipients.⁵ Patients received texts four times daily—timed to their immunosuppressant dosing—plus educational content three times weekly over three months.

Results: intervention patients scored significantly higher on medication adherence (48.7 vs. 45.6, p<0.001). Tacrolimus blood levels—the objective marker of whether patients actually take their medications—improved correspondingly.

The critical nuance: two-way messaging outperforms one-way. A meta-analysis found two-way texting—where patients confirm medication intake—showed 23% improvement in adherence versus controls. One-way messaging? Just 4%, not statistically significant.⁶

Why the difference? Two-way communication creates accountability, enables real-time problem-solving, and makes patients feel genuinely connected to their care team.

Multicomponent interventions move the needle

The TAKE-IT trial tested a comprehensive digital intervention in adolescent and young adult kidney transplant recipients—the population with the highest nonadherence rates and worst graft outcomes.⁷

The intervention combined electronic monitoring, patient-selected reminders, and quarterly coaching sessions where patients reviewed their adherence data and problem-solved barriers.

Results: intervention patients had 66% greater odds of taking their medications (OR 1.66) and 74% greater odds of taking them on time (OR 1.74).

The mechanism matters. Patients chose their preferred reminder modality. They reviewed their own data. They identified their own barriers and solutions with coach support. Technology provided measurement and prompts; human connection drove behavior change.

AI personalization: from promise to proof

The REINFORCE trial tested reinforcement learning—an AI approach that learns which message content works for each patient and adapts over time.⁸

Results: the intervention improved absolute adherence by 13.6% versus control. In patients with moderately elevated HbA1c, the effect reached 36.6% absolute improvement.

A 2025 systematic review of AI-based adherence tools confirmed the pattern: AI interventions improved adherence by 6.7% to 32.7% compared to controls across multiple RCTs.⁹

The implication: personalization works. Messages that adapt to individual responses—learning which content resonates, which timing works, which framing motivates—outperform static protocols. AI enables this at scale.

Evidence from adjacent fields

Other healthcare domains reinforce these principles.

Connected monitoring doubles effectiveness. Hypertension patients using home monitoring with pharmacist-led web communication achieved nearly twice the blood pressure control rate at 12 months (56% vs. 31%).¹⁰

Patient-reported outcomes save lives. Cancer patients reporting symptoms digitally during chemotherapy had fewer emergency visits and better overall survival.¹¹

Tech-enabled services reduce readmissions. Interventions combining remote monitoring with human touchpoints significantly reduce hospitalizations across chronic conditions.¹²

The peer support multiplier

Clinical tools matter, but peer support provides something different: lived experience.

Patients who connect with others who've walked the same path show improved emotional well-being, self-efficacy, and adherence.¹³ Peer support bridges the gap between what providers recommend and what daily life actually looks like.

Transplant communities already exist—TransplantLyfe, Facebook groups, UNOS forums, hospital programs. The opportunity: integrate these resources into digital care, connecting patients with relevant peers and normalizing the challenges everyone faces.

Building comprehensive engagement

Effective transplant engagement combines:

• Structured digital workflows guiding patients through care complexity
• Two-way messaging providing real-time support and accountability
• AI-enhanced personalization adapting content to individual response patterns
• Multicomponent interventions integrating monitoring, reminders, and coaching
• Integrated peer support throughout recovery
• Clinician-in-the-loop escalation for identified risks

Implementation challenges are real: ensuring accessibility without overload, addressing cultural and linguistic diversity, maintaining AI transparency, and measuring outcomes with validated tools—tacrolimus IPV, BAASIS assessments, hospitalization rates, graft survival.

The foundation, not the feature

Patient engagement isn't an add-on to transplant care. It's the foundation that determines whether surgical success translates to lasting health.

The evidence converges: digital tools, AI personalization, and human support transform outcomes when implemented together. The 2025 kidney transplant meta-analysis confirms eHealth works—but only with the right design. Static reminders fail. Two-way communication succeeds. Technology alone shows high attrition. Technology plus human coaching sustains behavior change.

At Stitch, we're building exactly this infrastructure: AI-enhanced workflows combined with human care coordination to keep transplant patients engaged from discharge through long-term recovery.

The transplant succeeded. Now we make sure the patient does too.

References

1. Butler JA, Roderick P, Mullee M, Mason JC, Peveler RC. Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review. Transplantation. 2004;77(5):769-776.
2. Pinsky BW, Takemoto SK, Lentine KL, et al. Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression. Am J Transplant. 2009;9(11):2597-2606.
3. Zhou L, Cheng K, Chen L, et al. Effectiveness of eHealth for medication adherence in renal transplant recipients: systematic review and meta-analysis. J Med Internet Res. 2025;27:e73520.
4. Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff (Millwood). 2013;32(2):207-214.
5. Erdal K, Karazeybek E. Impact of text message reminders on immunosuppressive medication adherence among kidney transplant recipients: a randomized controlled study. J Eval Clin Pract. 2025;31(1):e14178.
6. Wald DS, Butt S, Bestwick JP. One-way versus two-way text messaging on improving medication adherence: meta-analysis of randomized trials. Am J Med. 2015;128(10):1139.e1-1139.e5.
7. Foster BJ, Pai ALH, Zelikovsky N, et al. A randomized trial of a multicomponent intervention to promote medication adherence: the Teen Adherence in Kidney Transplant Effectiveness of Intervention Trial (TAKE-IT). Am J Kidney Dis. 2018;72(1):30-41.
8. Lauffenburger JC, Yom-Tov E, Keller PA, et al. The impact of using reinforcement learning to personalize communication on medication adherence: findings from the REINFORCE trial. NPJ Digit Med. 2024;7:39.
9. Reis Z, Pereira G, Dias C, et al. Artificial intelligence-based tools for patient support to enhance medication adherence: a focused review. Front Digit Health. 2025;7:1523070.
10. Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control. JAMA. 2008;299(24):2857-2867.
11. Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: overall survival results. JAMA. 2017;318(2):197-198.
12. Ezeamii VC, et al. Revolutionizing Healthcare: How Telemedicine Is Improving Patient Outcomes and Expanding Access to Care. Cureus. 2024;16(7):e63881.
13. Dew MA, et al. Peer mentoring for kidney transplant recipients: a randomized controlled trial of feasibility and efficacy. Clin Transplant. 2018;32(8):e13358.

‍

---

‍

This is what patients actually experience.
Read the story of the first year →

The economics are staggering.
See the $2.5B readmission opportunity →

‍